- Home
- CWD vs NUWE Comparison
CWD vs NUWE Comparison
Compare CWD & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CWD
- NUWE
- Stock Information
- Founded
- CWD 2009
- NUWE 1999
- Country
- CWD United States
- NUWE United States
- Employees
- CWD N/A
- NUWE N/A
- Industry
- CWD Real Estate
- NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CWD Finance
- NUWE Health Care
- Exchange
- CWD Nasdaq
- NUWE Nasdaq
- Market Cap
- CWD 4.7M
- NUWE 3.9M
- IPO Year
- CWD 2023
- NUWE N/A
- Fundamental
- Price
- CWD $3.54
- NUWE $0.23
- Analyst Decision
- CWD
- NUWE Strong Buy
- Analyst Count
- CWD 0
- NUWE 1
- Target Price
- CWD N/A
- NUWE $17.00
- AVG Volume (30 Days)
- CWD 18.6K
- NUWE 30.9M
- Earning Date
- CWD 08-11-2025
- NUWE 08-12-2025
- Dividend Yield
- CWD N/A
- NUWE N/A
- EPS Growth
- CWD N/A
- NUWE N/A
- EPS
- CWD N/A
- NUWE N/A
- Revenue
- CWD $35,429,000.00
- NUWE $8,787,000.00
- Revenue This Year
- CWD N/A
- NUWE $6.53
- Revenue Next Year
- CWD $31.12
- NUWE $51.63
- P/E Ratio
- CWD N/A
- NUWE N/A
- Revenue Growth
- CWD N/A
- NUWE N/A
- 52 Week Low
- CWD $3.00
- NUWE $0.21
- 52 Week High
- CWD $18.40
- NUWE $6.61
- Technical
- Relative Strength Index (RSI)
- CWD 44.15
- NUWE 26.12
- Support Level
- CWD $3.18
- NUWE $0.21
- Resistance Level
- CWD $3.90
- NUWE $0.32
- Average True Range (ATR)
- CWD 0.39
- NUWE 0.07
- MACD
- CWD 0.07
- NUWE 0.00
- Stochastic Oscillator
- CWD 30.77
- NUWE 11.43
About CWD CaliberCos Inc.
CaliberCos Inc is an asset management firm whose primary goal is to enhance the wealth of investors seeking to make investments in middle-market assets. The company's funds include investment vehicles focused on real estate, private equity, and debt facilities. The company earns asset management fees calculated as a percentage of managed capital in funds and offerings. The company markets services through direct sales to private investors, wholesaling to investment advisers, direct sales to family offices and institutions and through in-house client services. The company operates into three reportable segments: Fund Management, Development, and Brokerage. The majority of revenue is derived from the fund management fees segment.
About NUWE Nuwellis Inc.
Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.